Allergic Rhinitis Treatment Market, by Treatment Type (Immunotherapy (SCIT, SLITD, and SLITT), Anti-histamines, Decongestants, Leukotriene Receptor Antagonists, and Corticosteroids), by Route of Administration (Oral, Nasal, Intraocular, and Intravenous),

Allergic Rhinitis Treatment Market, by Treatment Type (Immunotherapy (SCIT, SLITD, and SLITT), Anti-histamines, Decongestants, Leukotriene Receptor Antagonists, and Corticosteroids), by Route of Administration (Oral, Nasal, Intraocular, and Intravenous), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and E-commerce), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Allergic rhinitis or hay fever is an IgE-mediated disorder caused by allergens such as mold or tress, animal, dander, house dust mites, weed pollens, and grass. It can occur in two different forms namely, seasonal and perennial, which in turn causes mild or moderate to severe inflammation inside the nose. Some of the major symptoms of allergic rhinitis include nasal congestion, rhinorrhea, sneezing, nasal itching, itchy eyes, stuffy nose, headache, pressure in the nose and cheeks, ear fullness and popping, sore throat, watery, red, or swollen eyes, dark circles under your eyes, trouble smelling, etc. Allergic rhinitis can also be associated with asthma and eczema. Allergic rhinitis and sinusitis are linked to each other, as allergic rhinitis blocks the nose, which in turn blocks the sinuses. Various treatments are available for allergic rhinitis which includes nasal steroid sprays, antihistamines, decongestants, leukotriene inhibitors, allergy shots or sublingual tablets, etc. Allergic rhinitis can lead to complications in some cases such as nasal polyps- abnormal but non-cancerous (benign) sacs of fluid that grow inside the nasal passages and sinuses, sinusitis – an infection caused by nasal inflammation and swelling and middle ear infections.

Market Dynamics

Increasing collaborations for advancing research in allergen immunotherapy is expected to propel the market growth during the forecast period. For instance, in July 2021, Stallergenes Greer, one of the global healthcare companies specializing in allergen immunotherapy, announced a research collaboration with Alyatec, a contract research organization based in Strasbourg University Hospital (France). In this collaboration, Stallergenes Greer is focused on a precision medicine-based approach and the management of patients with allergies with the help of Alyatec’s competencies in research and clinical services.

Key features of the study:

• This report provides in-depth analysis of the global allergic rhinitis treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global allergic rhinitis treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc. Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Glenmark Pharmaceuticals Ltd, Himalaya Wellness Company, Regeneron Pharmaceuticals Inc., Allergy Therapeutics, Stallergenes Greer, Bayer AG, Dr. Reddy’s Laboratories Ltd, ALK-Abelló A/S, Revolo Biotherapeutics among other prominent players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global allergic rhinitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic rhinitis treatment market

Detailed Segmentation:

• Global Allergic Rhinitis Treatment Market, By Treatment Type:
• Immunotherapy
• SCIT
• SLITD
• SLITT
• Anti-histamines
• Decongestants
• Leukotriene Receptor Antagonists
• Corticosteroids
• Global Allergic Rhinitis Treatment Market, By Route of Administration:
• Oral
• Nasal
• Intraocular
• Intravenous
• Global Allergic Rhinitis Treatment Market, By Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies
• E-commerce
• Global Allergic Rhinitis Treatment Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Merck & Co., Inc.
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Boehringer Ingelheim International GmbH
• AstraZeneca
• GSK plc.
• Johnson & Johnson Services, Inc.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Mylan N.V.
• Aytu BioPharma, Inc.
• Glenmark Pharmaceuticals Ltd
• Himalaya Wellness Company
• Regeneron Pharmaceuticals Inc.
• Allergy Therapeutics
• Stallergenes Greer, Bayer AG
• Bayer AG
• Reddy’s Laboratories Ltd
• ALK-Abelló A/S
• Revolo Biotherapeutics

“*” marked represents similar segmentation in other categories in the respective section.